PRKAA1 and Hyperinsulinemia: Berberine activates AMPK in pancreatic β cells (125) and regulates insulin gene transcription by inhibiting the expression of mouse insulin promoter, mRNA, and protein through the AMPK pathway, thereby playing a therapeutic role in T2DM with hyperinsulinemia (123).